Drug discount agreement according to Section 130a Paragraph 8 SGB V in conjunction with Section 130c Paragraph 1 SGB V for the drugs Alprolix (B02BD04), Elocta (B02BD02) and Altuvoct (B02BD02) for the treatment of hemophilia Drug discount...
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Contract Description
Drug discount agreement according to Section 130a Paragraph 8 SGB V in conjunction with Section 130c Paragraph 1 SGB V for the drugs Alprolix (B02BD04), Elocta (B02BD02) and Altuvoct (B02BD02) for the treatment of hemophilia Drug discount agreement according to Section 130a Paragraph 8 SGB V in conjunction with Section 130c Paragraph 1 SGB V for the drugs Alprolix (B02BD04), Elocta (B02BD02) and Altuvoct (B02BD02) for the treatment of hemophilia
The subject of this contract is the agreement of discounts in accordance with Section 130a Paragraph 8 SGB V in conjunction with Section 130c Paragraph 1 SGB V for the finished medicinal products Alprolix (B02BD04), Elocta (B02BD02) and Altuvoct (B02BD02) of the contractor, which are at the expense of the client during the term of the contract at the applicable rate Drug prescription sheet (e.g. sample 16 or sample e16A of the form agreement or the form agreement digital forms for the BMV-Ä).
Related Procurement Opportunities
Similar tenders in Pharmaceuticals, Healthcare and Medicine, Healthcare Equipment and Services